Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2017 (2017), Article ID 7952782, 8 pages
https://doi.org/10.1155/2017/7952782
Case Report

Zinc Chloride Smoke Inhalation Induced Severe Acute Respiratory Distress Syndrome: First Survival in the United States with Extended Duration (Five Weeks) Therapy with High Dose Corticosteroids in Combination with Lung Protective Ventilation

1University of Nevada School of Medicine, Reno, NV, USA
2Renown Regional Medical Center, Reno, NV, USA
3U.S. Department of Veteran Affairs, Ioannis A. Lougaris Veteran Affairs Medical Center, Reno, NV, USA

Correspondence should be addressed to Hafiz Mahboob; ude.adaven.enicidem@boobhamh

Received 1 May 2017; Accepted 21 June 2017; Published 26 July 2017

Academic Editor: Kurt Lenz

Copyright © 2017 Hafiz Mahboob et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C.-F. Chian, C.-P. Wu, C.-W. Chen, W.-L. Su, C.-B. Yeh, and W.-C. Perng, “Acute respiratory distress syndrome after zinc chloride inhalation: Survival after extracorporeal life support and corticosteroid treatment,” American Journal of Critical Care, vol. 19, no. 1, pp. 86–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Pettilä, O. Takkunen, and P. Tukiainen, “Zinc chloride smoke inhalation: A rare cause of severe acute respiratory distress syndrome,” Intensive Care Medicine, vol. 26, no. 2, pp. 215–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Homma, R. Jones, J. Qvist, W. M. Zapol, and L. Reid, “Pulmonary vascular lesions in the adult respiratory distress syndrome caused by inhalation of zinc chloride smoke: A morphometric study,” Human Pathology, vol. 23, no. 1, pp. 45–50, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Gil, A. Pla, A. F. Hernández, J. M. Mercado, and F. Méndez, “A fatal case following exposure to zinc chloride and hexachloroethane from a smoke bomb in a fire simulation at a school,” Clinical Toxicology, vol. 46, no. 6, pp. 563–565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. B. Schenker, F. E. Speizer, and J. O. Taylor, “Acute upper respiratory symptoms resulting from exposure to zinc chloride aerosol,” Environmental Research, vol. 25, no. 2, pp. 317–324, 1981. View at Publisher · View at Google Scholar · View at Scopus
  6. M. B. Macaulay and A. K. Mant, “Smoke-bomb poisoning. a fatal case following the inhalation of zinc chloride smoke,” Journal of the Royal Army Medical Corps, vol. 110, pp. 27–32, 1964. View at Google Scholar
  7. E. Evans, “CASUALTIES FOLLOWING EXPOSURE TO ZINC CHLORIDE SMOKE,” The Lancet, vol. 246, no. 6369, pp. 368–370, 1945. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Zerahn, A. Kofoed-Enevoldsen, B. V. Jensen et al., “Pulmonary damage after modest exposure to zinc chloride smoke,” Respiratory Medicine, vol. 93, no. 12, pp. 885–890, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Hjortsø, J. Ovist, M. I. Bud et al., “ARDS after accidental inhalation of zinc chloride smoke,” Intensive Care Medicine, vol. 14, no. 1, pp. 17–24, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Matarese and J. I. Matthews, “Zinc chloride (smoke bomb) inhalation lung injury,” Chest, vol. 89, no. 2, pp. 308-309, 1986. View at Publisher · View at Google Scholar · View at Scopus
  11. P. S. Holmes, “Pneumomediastinum associated with inhalation of white smoke,” Military Medicine, vol. 164, pp. 751-752, 1999. View at Google Scholar
  12. J. A. Milliken, D. Waugh, and M. E. Kadish, “Acute interstitial pulmonary fibrosis caused by a smoke bomb,” Canadian Medical Association Journal, vol. 88, pp. 36–39, 1963. View at Google Scholar
  13. M. B. P. Amato, C. S. V. Barbas, D. M. Medeiros et al., “Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 338, no. 6, pp. 347–354, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. R. G. Brower, M. A. Matthay, A. Morris, D. Schoenfeld, B. T. Thompson, and A. Wheeler, “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Luce, “Acute lung injury and the acute respiratory distress syndrome,” Critical Care Medicine, vol. 26, no. 2, pp. 369–376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. B. Allen, A. Crisp, N. Snook, and R. L. Page, “'Smoke-bomb' pneumonitis,” Respiratory Medicine, vol. 86, no. 2, pp. 165-166, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. R. W. Taylor, J. L. Zimmerman, R. P. Dellinger et al., “Low-Dose Inhaled Nitric Oxide in Patients with Acute Lung Injury: A Randomized Controlled Trial,” Journal of the American Medical Association, vol. 291, no. 13, pp. 1603–1609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Afshari, J. Brok, A. M. Moller, and J. Wetterslev, “Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS),” Cochrane Database of Systematic Reviews, no. 8, CD007733, 2010. View at Google Scholar
  19. P. Dahlem, W. M. C. Van Aalderen, M. De Neef, M. G. W. Dijkgraaf, and A. P. Bos, “Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury,” Critical Care Medicine, vol. 32, no. 4, pp. 1055–1060, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Dunkley, P. R. Louzon, J. Lee, and S. Vu, “Efficacy, safety, and medication errors associated with the use of inhaled epoprostenol for adults with acute respiratory distress syndrome: A pilot study,” Annals of Pharmacotherapy, vol. 47, no. 6, pp. 790–796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Torbic, P. M. Szumita, K. E. Anger, P. Nuccio, S. LaGambina, and G. Weinhouse, “Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients,” Journal of Critical Care, vol. 28, no. 5, pp. 844–848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Guérin, J. J.-C. Reignier, P. Richard et al., “Prone positioning in severe acute respiratory distress syndrome,” New England Journal of Medicine, vol. 368, pp. 2159–2168, 2013. View at Google Scholar
  23. C. M. Romero, R. A. Cornejo, L. R. Gálvez et al., “Extended prone position ventilation in severe acute respiratory distress syndrome: A pilot feasibility study,” Journal of Critical Care, vol. 24, no. 1, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. H. Bartlett, D. W. Roloff, J. R. Custer, J. G. Younger, and R. B. Hirschl, “Extracorporeal life support: the University of Michigan Experience,” JAMA: the Journal of the American Medical Association, vol. 283, no. 7, pp. 904–908, 2000. View at Google Scholar
  25. M. D. Mitchell, M. E. Mikkelsen, C. A. Umscheid, I. Lee, B. D. Fuchs, and S. D. Halpern, “A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic,” Critical Care Medicine, vol. 38, no. 6, pp. 1398–1404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Extracorporeal Life Support Organization, https://www.elso.org/.
  27. S. Kolla, S. S. Awad, P. B. Rich, R. J. Schreiner, R. B. Hirschl, and R. H. Bartlett, “Extracorporeal life support for 100 adult patients with severe respiratory failure,” Annals of Surgery, vol. 226, no. 4, pp. 544–566, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. G. J. Peek, M. Mugford, and R. Tiruvoipati, “Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial,” The Lancet, vol. 374, no. 9698, pp. 1351–1363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Patroniti, A. Zangrillo, F. Pappalardo et al., “The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks,” Intensive Care Medicine, vol. 37, no. 9, pp. 1447–1457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Brodie and M. Bacchetta, “Extracorporeal membrane oxygenation for ARDS in adults,” New England Journal of Medicine, vol. 365, no. 20, pp. 1905–1914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. O. Meade, D. J. Cook, G. H. Guyatt et al., “Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial,” JAMA, vol. 299, no. 6, pp. 637–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Bein, S. Weber-Carstens, A. Goldmann et al., “Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study,” Intensive Care Medicine, vol. 39, no. 5, pp. 847–856, 2013. View at Publisher · View at Google Scholar
  33. A. P. Wheeler and G. R. Bernard, “Acute lung injury and the acute respiratory distress syndrome: a clinical review,” The Lancet, vol. 369, no. 9572, pp. 1553–1564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Ishimoto, K. Yatera, K. Oda et al., “Two cases of acute respiratory distress syndrome related to zinc fumes and zinc dust inhalation,” Journal of UOEH, vol. 36, no. 2, pp. 147–152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. F. A. Johnson and R. B. Stonehil, “Chemical pneumonitis from inhalation of zinc chloride,” Chest, vol. 40, pp. 619–624, 1961. View at Google Scholar
  36. A. Ashok Kalanuria and W. Zai, “Email author and Marek Mirski: ventilator-associated pneumonia in the ICU,” Critical Care, vol. 18, no. 2, 208 pages, 2014. View at Publisher · View at Google Scholar
  37. S. Tongyoo, C. Permpikul, W. Mongkolpun et al., “Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial,” Critical Care, vol. 20, no. 1, article no. 329, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. R. D. Stevens, D. W. Dowdy, R. K. Michaels, P. A. Mendez-Tellez, P. J. Pronovost, and D. M. Needham, “Neuromuscular dysfunction acquired in critical illness: A systematic review,” Intensive Care Medicine, vol. 33, no. 11, pp. 1876–1891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. R. I. Thiele, H. Jakob, E. Hund et al., “Critical illness polyneuropathy: A new iatrogenically induced syndrome after cardiac surgery?” European Journal of Cardio-thoracic Surgery, vol. 12, no. 6, pp. 826–835, 1997. View at Publisher · View at Google Scholar · View at Scopus